Zymeworks Inc
General ticker "ZYME" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.0B
Zymeworks Inc follows the US Stock Market performance with the rate: 44.6%.
Estimated limits based on current volatility of 3.5%: low 13.14$, high 14.10$
Factors to consider:
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [6.71$, 13.34$]
- 2024-12-30 to 2025-12-30 estimated range: [5.71$, 11.87$]
Financial Metrics affecting the ZYME estimates:
- Negative: Non-GAAP EPS, $ of -1.74 <= 0.10
- Negative: Operating profit margin, % of -64.49 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -15.71 <= 2.35
- Positive: -3.48 < Investing cash flow per share, $ of -3.01
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term ZYME quotes
Long-term ZYME plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $26.68MM | $412.48MM | $76.01MM |
| Operating Expenses | $242.31MM | $281.95MM | $214.06MM |
| Operating Income | $-215.63MM | $130.53MM | $-138.05MM |
| Non-Operating Income | $3.27MM | $4.71MM | $18.81MM |
| Interest Expense | $0.00MM | $3.60MM | $0.00MM |
| R&D Expense | $199.75MM | $208.60MM | $143.62MM |
| Income(Loss) | $-212.36MM | $135.23MM | $-119.24MM |
| Taxes | $-0.52MM | $10.89MM | $-0.57MM |
| Profit(Loss) | $-211.84MM | $124.34MM | $-118.67MM |
| Stockholders Equity | $249.09MM | $492.96MM | $464.81MM |
| Assets | $389.13MM | $648.73MM | $580.88MM |
| Operating Cash Flow | $-192.45MM | $144.11MM | $-118.30MM |
| Capital expenditure | $13.29MM | $13.12MM | $4.08MM |
| Investing Cash Flow | $144.60MM | $-53.85MM | $-207.25MM |
| Financing Cash Flow | $8.01MM | $108.58MM | $81.85MM |
| Earnings Per Share* | $-4.06 | $1.91 | $-1.72 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.